Category: C.R. BardSyndicate content

Supreme Court declines to hear appeal by Mirowski Family Ventures | Medtech legal news for the week of October 20, 2014

October 20, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Supreme Court passes on Mirowski-Medtronic patent case; Medtronic can't shake shareholders lawsuit over Infuse; FDA strikes out again in Prevor drug-or-device case; Ex-Bard, BD engineer gets 18 months for stealing trade secrets; Appeals court: Fujifilm Medical executive wasn't fired for not being Japanese

Supreme Court passes on Mirowski-Medtronic patent case

October 15, 2014 by Val Kennedy

Ex-Bard, BD engineer gets 18 months for stealing trade secrets

October 17, 2014 by Brad Perriello

A former engineer for Becton, Dickinson & Co. and C.R. Bard who confessed to stealing trade secrets concerning an injector pen is sentenced to 18 months in prison.

Ex-Bard, BD engineer gets 18 months for stealing trade secrets

3rd FDA panel barely favors BSX's Watchman | Regulatory news for the week of October 13, 2014

October 14, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: 3rd FDA panel vote barely favors Boston Scientific's Watchman anti-stroke device; Medtronic launches Verify incontinence device in the U.S.; FDA OKs Integra Lifesciences Puerto Rico plant; FDA approves Bard's Lutonix DEB

UPDATE: 3rd FDA panel vote barely favors Boston Scientific's Watchman anti-stroke device

October 9, 2014 by Brad Perriello

Medtronic shareholder sues over company's plan to cover nearly $58M in taxes | Medtech legal news for the week of October 13, 2014

October 13, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Shareholder sues Medtronic over plan to cover execs' $58m tax tab; Report: Bard's mesh settlement is worth $21m; Covidien's Ev3 logs a pair of legal wins over Appriva, whistleblower; BD loses bid to overturn $114m antitrust loss to Retractable Technologies; Ex-Oriole DeCinces fights insider trading charges

Shareholder sues Medtronic over plan to cover execs' $58m tax tab

October 7, 2014 by Brad Perriello

FDA approves Bard's Lutonix DEB

October 10, 2014 by Brad Perriello

The FDA grants pre-market approval for C.R. Bard's Lutonix drug-eluting balloon for treating peripheral artery disease.

FDA approves Bard's Lutonix DEB

C.R. Bard (NYSE:BCR) said today that the FDA granted pre-market approval for its Lutonix drug-eluting balloon for treating peripheral artery disease, well ahead of the company's expectation for approval early next year.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Report: Bard's mesh settlement is worth $21m

October 9, 2014 by Brad Perriello

The deal inked by C.R. Bard to settle a raft of product liability lawsuits brought over its pelvic mesh implants is reportedly worth more than $21 million.

Report: Bard's mesh settlement is worth $21m

The deal between C.R. Bard (NYSE:BCR) and a pair of law firms representing 500 plaintiffs in product liability lawsuits brought over its pelvic mesh implants is reportedly worth $21 million.

Ex-ArthroCare execs face hefty prison sentences | Medtech legal news for the week of September 8, 2014

September 8, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Ex-ArthroCare CEO Baker draws 20 years; Smith & Nephew settles whistleblower lawsuit for $8M; Secant Medical escapes pelvic mesh cases; Bellwether trial kicks off for DePuy's Pinnacle hip implant; J&J, Boston Scientific, others can't shake Philly pelvic mesh mass tort

Ex-ArthroCare CEO Baker draws 20 years

September 2, 2014 by Brad Perriello

Ex-ArthroCare CEO Baker draws 20 years
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp